Acquisition Signals Recent asset sale to DeRoyal Industries suggests potential channel and integration opportunities through resellers or legacy product transitions. Sales teams should explore partnerships or bundled offerings with DeRoyal or related distributors to leverage installed STREAMWAY assets and customer base.

Regulatory Rationale The STREAMWAY System is FDA-cleared and designed to automate waste fluid disposal, reducing exposure risk and operating costs. This positions Skyline Medical well for hospitals and clinics prioritizing patient safety, regulatory compliance, and cost containment in procurement rationales.

Hospital Footprint Product installed in operating rooms and procedure rooms with wall-mounted design offers a space-saving, accessible solution. Targeted outreach to OR managers, infection control, and facilities teams across mid-sized to large hospital networks could yield upsell opportunities and service contracts.

Growth History Past partnerships and planned acquisitions (e.g., Helomics collaboration, Quantitative Medicine LOI) indicate a strategy of integrating analytics and biotech capabilities. Upsell or cross-sell opportunities exist with analytics-enabled care pathways and value-based procurement in tertiary care and research institutions.

Financial Levers Revenue scale is modest with stated funding and growth potential. Emphasize total cost of ownership, predictable maintenance, and financing or leasing options to convert small-to-mid market buyers and accelerate adoption among facilities budgets.